MiNK Therapeutics Presents New Data of allo-iNKT Cell Therapy as a Potential Disease-Modifying ...

MiNK Therapeutics Presents New Data of allo-iNKT Cell Therapy as a Potential Disease-Modifying ...

Human lung tissue analyses identify iNKT cell depletion as a mechanistic feature of advanced IPFFindings extend MiNK’s iNKT platform into chronic fibrotic lung disease and support immune restoration strategies in IPF, a large unmet-need market

MiNK Therapeutics Reports Preclinical Data Showing Anti-Fibrotic Effects of Allo-iNKT Cell Therapy for Idiopathic Pulmonary Fibrosis

MiNK Therapeutics has presented new data on its allo-iN […] The post MiNK Therapeutics Reports Preclinical Data Showing Anti-Fibrotic Effects of Allo-iNKT Cell Therapy for Idiopathic Pulmonary Fibrosis first appeared on GeneOnline News. The post MiNK Therapeutics Reports Preclinical Data Showing Anti-Fibrotic Effects of Allo-iNKT Cell Therapy for Idiopathic Pulmonary Fibrosis appeared first on GeneOnline News.

New IPF lung data: key immune cells depleted in advanced disease

IPF kills within 3–5 years and affects ~100,000 Americans; MiNK’s Keystone data link advanced cases to depleted iNKT cells, supporting cell therapy.